• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化伴门静脉高压患者的减重手术:高危患者 Roux-en-Y 胃旁路手术的构建与特殊性

Bariatric Surgery in the Setting of Liver Cirrhosis with Portal Hypertension: the Confection and Particularities of Roux-en-Y Gastric Bypass in a High-Risk Patient.

作者信息

Frey Sebastien, Petrucciani Niccolo, Iannelli Antonio

机构信息

Université Côte d'Azur, Nice, France.

Digestive Surgery and Liver Transplantation Unit, Centre Hospitalier Universitaire de Nice, Archet 2 Hospital, Nice, France.

出版信息

Obes Surg. 2020 Oct;30(10):4165-4166. doi: 10.1007/s11695-020-04715-w. Epub 2020 Jul 27.

DOI:10.1007/s11695-020-04715-w
PMID:32720262
Abstract

INTRODUCTION

Morbid obesity is associated with the occurrence of non-alcoholic fatty liver disease, which may progress to cirrhosis. Although weight loss is the treatment of choice, surgical management can be challenging at the stage of cirrhosis. The aim of this video report is to present the confection and the features of a Roux-en-Y gastric bypass (RYGB) in the setting of liver cirrhosis.

METHODS

We present the case of a 60-year-old man with a weight of 115 kg and a corresponding BMI of 38.9 kg/m, with non-alcoholic steatohepatitis (NASH)-related liver cirrhosis. The latter was compensated (Child-Turcott-Pugh score at A6) but the patient had already undergone three esophageal variceal ligations. Portal hypertension with splenomegaly was clearly visible on preoperative workup.

RESULTS

In this video, we show how to perform RYGB in a case of liver cirrhosis, with a focus on common pitfalls. The main risks remain perioperative bleeding due to portal hypertension and impaired coagulation, as well as the decompensation of the cirrhosis. A careful preoperative nutritional and hepatological evaluation is mandatory since the perioperative risk of morbidities is higher.

CONCLUSION

RYGB is a feasible option in selected patients with morbid obesity and cirrhosis. These patients ideally should be managed in centers having experience in bariatric surgery and hepatology.

摘要

引言

病态肥胖与非酒精性脂肪性肝病的发生有关,后者可能进展为肝硬化。尽管减肥是首选治疗方法,但在肝硬化阶段进行手术治疗可能具有挑战性。本视频报告的目的是介绍肝硬化患者 Roux-en-Y 胃旁路术(RYGB)的操作过程及特点。

方法

我们报告一例 60 岁男性患者,体重 115 千克,体重指数(BMI)为 38.9kg/m²,患有非酒精性脂肪性肝炎(NASH)相关肝硬化。该患者肝硬化处于代偿期(Child-Turcott-Pugh 评分 A6 级),但已接受过三次食管静脉曲张结扎术。术前检查清晰显示门静脉高压伴脾肿大。

结果

在本视频中,我们展示了如何在肝硬化患者中实施 RYGB,重点关注常见的陷阱。主要风险仍然是门静脉高压和凝血功能受损导致的围手术期出血,以及肝硬化失代偿。由于围手术期发病风险较高,术前进行仔细的营养和肝脏评估是必不可少的。

结论

RYGB 对于选定的病态肥胖和肝硬化患者是一种可行的选择。这些患者理想情况下应在有减肥手术和肝病治疗经验的中心接受治疗。

相似文献

1
Bariatric Surgery in the Setting of Liver Cirrhosis with Portal Hypertension: the Confection and Particularities of Roux-en-Y Gastric Bypass in a High-Risk Patient.肝硬化伴门静脉高压患者的减重手术:高危患者 Roux-en-Y 胃旁路手术的构建与特殊性
Obes Surg. 2020 Oct;30(10):4165-4166. doi: 10.1007/s11695-020-04715-w. Epub 2020 Jul 27.
2
Outcomes of Bariatric Surgery in Patients with Liver Cirrhosis: a Systematic Review.肥胖症手术治疗肝硬化患者的效果:系统综述。
Obes Surg. 2021 May;31(5):2255-2267. doi: 10.1007/s11695-021-05289-x. Epub 2021 Feb 17.
3
Apprising the choice of bariatric surgery in patients with compensated cirrhosis with morbid obesity: results of a national analysis.评估病态肥胖代偿性肝硬化患者选择减重手术的情况:一项全国性分析的结果。
Updates Surg. 2021 Oct;73(5):1899-1908. doi: 10.1007/s13304-021-01142-z. Epub 2021 Aug 5.
4
The first Polish liver transplantation after Roux-en-Y gastric bypass surgery for morbid obesity: a case report and literature review.首例波兰病态肥胖患者经Roux-en-Y胃旁路手术后的肝移植:病例报告及文献综述
Ann Transplant. 2015 Feb 25;20:112-5. doi: 10.12659/AOT.893797.
5
Bariatric surgery in individuals with liver cirrhosis: A narrative review.肝硬化患者的减重手术:一项叙述性综述。
Rev Assoc Med Bras (1992). 2017 Feb;63(2):190-194. doi: 10.1590/1806-9282.63.02.190.
6
Bariatric Surgery in Patients with Cirrhosis and Portal Hypertension.肝硬化和门静脉高压症患者的减重手术。
Obes Surg. 2018 Nov;28(11):3431-3438. doi: 10.1007/s11695-018-3372-z.
7
Influence of Liver Disease on Perioperative Outcome After Bariatric Surgery in a Northern German Cohort.在德国北部的一个队列中,肝脏疾病对减肥手术后围手术期结局的影响。
Obes Surg. 2017 Jan;27(1):90-95. doi: 10.1007/s11695-016-2253-6.
8
Bariatric Surgery as an Efficient Treatment for Non-Alcoholic Fatty Liver Disease in a Prospective Study with 1-Year Follow-up : BariScan Study.前瞻性研究随访 1 年:BariScan 研究显示减重手术可有效治疗非酒精性脂肪性肝病。
Obes Surg. 2018 May;28(5):1342-1350. doi: 10.1007/s11695-017-3012-z.
9
Histologic improvement of NAFLD in patients with obesity after bariatric surgery based on standardized NAS (NAFLD activity score).基于标准化 NAS(非酒精性脂肪性肝病活动评分),肥胖症患者在接受减重手术后其非酒精性脂肪性肝病的组织学改善。
Surg Obes Relat Dis. 2018 Oct;14(10):1607-1616. doi: 10.1016/j.soard.2018.07.012. Epub 2018 Jul 24.
10
Impact of sleeve gastrectomy and Roux-en-Y gastric bypass on biopsy-proven non-alcoholic fatty liver disease.袖状胃切除术和 Roux-en-Y 胃旁路术对活检证实的非酒精性脂肪性肝病的影响。
Surg Endosc. 2020 May;34(5):2266-2272. doi: 10.1007/s00464-019-07017-0. Epub 2019 Jul 29.

引用本文的文献

1
Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss.非酒精性脂肪性肝病(NAFLD):病理生理学、临床管理和减肥效果的综述。
BMC Endocr Disord. 2022 Mar 14;22(1):63. doi: 10.1186/s12902-022-00980-1.
2
FGF19 and FGF21 for the Treatment of NASH-Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human.成纤维细胞生长因子19和21用于非酒精性脂肪性肝炎的治疗——同一枚硬币的两面?从小鼠到人类,成纤维细胞生长因子19和21的差异与重叠效应
Front Endocrinol (Lausanne). 2020 Dec 22;11:601349. doi: 10.3389/fendo.2020.601349. eCollection 2020.